KEGG   PATHWAY: ngi04270
Entry
ngi04270                    Pathway                                
Name
Vascular smooth muscle contraction - Nannospalax galili (Upper Galilee mountains blind mole rat)
Description
The vascular smooth muscle cell (VSMC) is a highly specialized cell whose principal function is contraction. On contraction, VSMCs shorten, thereby decreasing the diameter of a blood vessel to regulate the blood flow and pressure.
The principal mechanisms that regulate the contractile state of VSMCs are changes in cytosolic Ca2+ concentration ([Ca2+]c). In response to vasoconstrictor stimuli, Ca2+ is mobilized from intracellular stores and/or the extracellular space to increase [Ca2+]c in VSMCs. The increase in [Ca2+]c, in turn, activates the Ca2+-CaM-MLCK pathway and stimulates MLC20 phosphorylation, leading to myosin-actin interactions and, hence, the development of contractile force. The sensitivity of contractile myofilaments or MLC20 phosphorylation to Ca2+ can be secondarily modulated by other signaling pathways. During receptor stimulation, the contractile force is greatly enhanced by the inhibition of myosin phosphatase. Rho/Rho kinase, PKC, and arachidonic acid have been proposed to play a pivotal role in this enhancement.
The signaling events that mediate relaxation include the removal of a contractile agonist (passive relaxation) and activation of cyclic nucleotide-dependent signaling pathways in the continued presence of a contractile agonist (active relaxation). Active relaxation occurs through the inhibition of both Ca2+ mobilization and myofilament Ca2+ sensitivity in VSMCs.
Class
Organismal Systems; Circulatory system
Pathway map
ngi04270  Vascular smooth muscle contraction
ngi04270

Other DBs
GO: 0014829
Organism
Nannospalax galili (Upper Galilee mountains blind mole rat) [GN:ngi]
Gene
103732394  Adra1a; adrenoceptor alpha 1A [KO:K04135]
103724547  Adra1b; adrenoceptor alpha 1B [KO:K04136]
103736404  Adra1d; adrenoceptor alpha 1D [KO:K04137]
103744123  Agt; angiotensinogen [KO:K09821]
103737006  type-1 angiotensin II receptor [KO:K04166]
103745994  Agtr1; angiotensin II receptor type 1 [KO:K04166]
103732886  Edn1; endothelin 1 [KO:K16366]
103735998  Edn2; endothelin 2 [KO:K16367]
103741411  Edn3; endothelin 3 [KO:K05227]
103729397  Ednra; endothelin receptor type A [KO:K04197]
103744402  Avpr1a; arginine vasopressin receptor 1A [KO:K04226]
103725975  Avpr1b; arginine vasopressin receptor 1B [KO:K04227]
103734421  Gnaq; guanine nucleotide-binding protein G(q) subunit alpha [KO:K04634]
103737243  Gna11; G protein subunit alpha 11 [KO:K04635]
103736956  Pla2g12b; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]
103728585  Pla2g2c; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]
103740430  Pla2g3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]
103740198  Pla2g1b; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]
103742445  Pla2g12a; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]
103724725  Pla2g2a; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]
103724727  Pla2g2d; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]
103724726  Pla2g5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]
103724724  Pla2g2e; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]
103724729  Pla2g2f; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]
103731556  Pla2g10; group 10 secretory phospholipase A2 [KO:K01047] [EC:3.1.1.4]
103744946  Pla2g4d; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]
103744945  Pla2g4e; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]
103744942  Pla2g4b; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]
103744947  Pla2g4f; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]
103726649  Pla2g4a; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]
103732429  Pla2g4c; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]
103748592  Pla2g6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]
103740657  cytochrome P450 4A14-like [KO:K07425] [EC:1.14.14.80]
103747438  Kcnma1; potassium calcium-activated channel subfamily M alpha 1 [KO:K04936]
103748177  Kcnmb1; potassium calcium-activated channel subfamily M regulatory beta subunit 1 [KO:K04937]
103738599  Kcnmb2; potassium calcium-activated channel subfamily M regulatory beta subunit 2 [KO:K04938]
103738595  Kcnmb3; potassium calcium-activated channel subfamily M regulatory beta subunit 3 [KO:K04939]
103731661  Kcnmb4; potassium calcium-activated channel subfamily M regulatory beta subunit 4 [KO:K04941]
103739378  Cacna1c; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
103749025  Cacna1d; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
103741673  Cacna1f; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
103731814  Cacna1s; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
103737134  Calml3; calmodulin like 3 [KO:K02183]
103737133  Calml5; calmodulin like 5 [KO:K02183]
103749800  Calml6; calmodulin like 6 [KO:K02183]
103724616  Calm1; calmodulin 1 [KO:K02183]
103724738  Calm3; calmodulin 3 [KO:K02183]
103725745  Calm2; calmodulin 2 [KO:K02183]
103729208  calmodulin-alpha-like [KO:K02183]
103736816  Calml4; calmodulin like 4 [KO:K02183]
103731078  Mylk2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
103737011  Mylk4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]
103741992  Mylk; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]
103745443  Mylk3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
103746506  Myl6b; myosin light chain 6B [KO:K12751]
103746507  Myl6; myosin light chain 6 [KO:K12751]
103740213  Myl9; myosin light chain 9 [KO:K12755]
103748521  myosin regulatory light polypeptide 9 [KO:K12755]
103743690  Myh14; myosin heavy chain 14 [KO:K10352]
103752230  Myh10; myosin heavy chain 10 [KO:K10352]
103731546  Myh11; myosin heavy chain 11 [KO:K10352]
103751391  Myh9; myosin heavy chain 9 [KO:K10352]
103735195  Plcb1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
103738797  Plcb3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
103741502  Plcb2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
103751203  Itpr1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
103739696  Itpr3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
103742202  Prkca; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
103746928  Prkcb; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
103729666  Prkcg; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
103749021  Prkcd; protein kinase C delta [KO:K06068] [EC:2.7.11.13]
103725757  Prkce; protein kinase C epsilon [KO:K18050] [EC:2.7.11.13]
103747968  Prkch; protein kinase C eta [KO:K18051] [EC:2.7.11.13]
103727298  Prkcq; protein kinase C theta [KO:K18052] [EC:2.7.11.13]
103741627  Araf; A-Raf proto-oncogene, serine/threonine kinase [KO:K08845] [EC:2.7.11.1]
103726107  Braf; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
103751450  Raf1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
103736801  Map2k1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
103737276  Map2k2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
103741442  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
103726390  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
103726062  Cald1; caldesmon 1 [KO:K12327]
103738035  Acta2; actin, alpha 2, smooth muscle, aorta [KO:K12313]
103749947  Actg2; actin, gamma 2, smooth muscle, enteric [KO:K12315]
103750702  Ppp1r14a; protein phosphatase 1 regulatory inhibitor subunit 14A [KO:K12328]
103739088  Ppp1cc; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
103725581  Ppp1ca; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
103730228  Ppp1cb; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
103749250  Ppp1r12a; protein phosphatase 1 regulatory subunit 12A [KO:K06270]
103731836  Ppp1r12b; protein phosphatase 1 regulatory subunit 12B [KO:K12329]
103744825  Ppp1r12c; protein phosphatase 1 regulatory subunit 12C [KO:K17457]
103748670  Gna12; G protein subunit alpha 12 [KO:K04346]
103742208  Gna13; G protein subunit alpha 13 [KO:K04639]
103727935  Arhgef12; Rho guanine nucleotide exchange factor 12 [KO:K07532]
103744614  Arhgef1; Rho guanine nucleotide exchange factor 1 [KO:K12330]
103750204  Arhgef11; Rho guanine nucleotide exchange factor 11 [KO:K12331]
103743359  transforming protein RhoA-like [KO:K04513]
103750189  Rhoa; ras homolog family member A [KO:K04513]
103728977  Rock1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]
103747607  Rock2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
103736274  Adora2a; adenosine A2a receptor [KO:K04266]
103727344  Adora2b; adenosine A2b receptor [KO:K04267]
103724730  Ptgir; prostaglandin I2 (prostacyclin) receptor (IP) [KO:K04263]
103750429  calcitonin gene-related peptide 1-like [KO:K12332]
103750430  Calcb; calcitonin related polypeptide beta [KO:K12332]
103750400  Adm; adrenomedullin [KO:K12333]
103735481  Adm2; adrenomedullin 2 [KO:K25343]
103728770  Calcrl; calcitonin receptor like receptor [KO:K04577]
103726196  Ramp1; receptor activity modifying protein 1 [KO:K08447]
103735913  Ramp2; receptor activity modifying protein 2 [KO:K08448]
103735004  Ramp3; receptor activity modifying protein 3 [KO:K08449]
103741475  Gnas; GNAS complex locus [KO:K04632]
103741466  neuroendocrine secretory protein 55 [KO:K04632]
103741433  Adcy1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
103735350  Adcy2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
103746460  Adcy3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
103739411  Adcy4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
103741989  Adcy5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
103750558  Adcy6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
103730120  Adcy7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
103743923  Adcy8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
103744458  Adcy9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
103751850  Prkaca; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
103728095  Prkacb; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
103747472  Nppa; natriuretic peptide A [KO:K12334]
103747473  Nppb; natriuretic peptide B [KO:K12335]
103751781  Npr1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]
103738216  Nppc; natriuretic peptide C [KO:K12336]
103741534  Npr2; natriuretic peptide receptor 2 [KO:K12324] [EC:4.6.1.2]
103732508  Prkg1; protein kinase, cGMP-dependent, type I [KO:K07376] [EC:2.7.11.12]
103751001  Gucy1a3; guanylate cyclase 1 soluble subunit alpha [KO:K12318] [EC:4.6.1.2]
103731324  Gucy1a2; guanylate cyclase 1 soluble subunit alpha 2 [KO:K12318] [EC:4.6.1.2]
103751002  Gucy1b3; guanylate cyclase 1 soluble subunit beta [KO:K12319] [EC:4.6.1.2]
103727194  guanylate cyclase soluble subunit beta-2-like [KO:K12319] [EC:4.6.1.2]
Compound
C00076  Calcium cation
C00165  Diacylglycerol
C00212  Adenosine
C00219  Arachidonate
C00238  Potassium cation
C00533  Nitric oxide
C00547  L-Noradrenaline
C00575  3',5'-Cyclic AMP
C00942  3',5'-Cyclic GMP
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01312  Prostaglandin I2
C14748  20-HETE
C14768  5,6-EET
C14769  8,9-EET
C14770  11,12-EET
C14771  14,15-EET
Reference
  Authors
Akata T
  Title
Cellular and molecular mechanisms regulating vascular tone. Part 2: regulatory mechanisms modulating Ca2+ mobilization and/or myofilament Ca2+ sensitivity in vascular smooth muscle cells.
  Journal
J Anesth 21:232-42 (2007)
DOI:10.1007/s00540-006-0488-4
Reference
  Authors
Ogut O, Brozovich FV
  Title
Regulation of force in vascular smooth muscle.
  Journal
J Mol Cell Cardiol 35:347-55 (2003)
DOI:10.1016/S0022-2828(03)00045-2
Reference
  Authors
Hilgers RH, Webb RC
  Title
Molecular aspects of arterial smooth muscle contraction: focus on Rho.
  Journal
Exp Biol Med (Maywood) 230:829-35 (2005)
DOI:10.1177/153537020523001107
Reference
  Authors
Schlossmann J, Feil R, Hofmann F
  Title
Signaling through NO and cGMP-dependent protein kinases.
  Journal
Ann Med 35:21-7 (2003)
DOI:10.1080/07853890310004093
Reference
  Authors
Mehta PK, Griendling KK
  Title
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.
  Journal
Am J Physiol Cell Physiol 292:C82-97 (2007)
DOI:10.1152/ajpcell.00287.2006
Reference
  Authors
Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG
  Title
Smooth muscle signalling pathways in health and disease.
  Journal
J Cell Mol Med 12:2165-80 (2008)
DOI:10.1111/j.1582-4934.2008.00552.x
Reference
  Authors
Fukata Y, Amano M, Kaibuchi K
  Title
Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells.
  Journal
Trends Pharmacol Sci 22:32-9 (2001)
DOI:10.1016/S0165-6147(00)01596-0
Reference
  Authors
Dimopoulos GJ, Semba S, Kitazawa K, Eto M, Kitazawa T
  Title
Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle.
  Journal
Circ Res 100:121-9 (2007)
DOI:10.1161/01.RES.0000253902.90489.df
Reference
  Authors
Hynynen MM, Khalil RA
  Title
The vascular endothelin system in hypertension--recent patents and discoveries.
  Journal
Recent Pat Cardiovasc Drug Discov 1:95-108 (2006)
DOI:10.2174/157489006775244263
Reference
  Authors
Brain SD, Grant AD
  Title
Vascular actions of calcitonin gene-related peptide and adrenomedullin.
  Journal
Physiol Rev 84:903-34 (2004)
DOI:10.1152/physrev.00037.2003
Reference
  Authors
Roman RJ
  Title
P-450 metabolites of arachidonic acid in the control of cardiovascular function.
  Journal
Physiol Rev 82:131-85 (2002)
DOI:10.1152/physrev.00021.2001
Reference
  Authors
Surks HK
  Title
cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms.
  Journal
Circ Res 101:1078-80 (2007)
DOI:10.1161/CIRCRESAHA.107.165779
Reference
  Authors
Vanhoutte PM
  Title
Endothelium-dependent hyperpolarizations: the history.
  Journal
Pharmacol Res 49:503-8 (2004)
DOI:10.1016/j.phrs.2003.11.015
Reference
  Authors
Davis MJ, Hill MA
  Title
Signaling mechanisms underlying the vascular myogenic response.
  Journal
Physiol Rev 79:387-423 (1999)
DOI:10.1152/physrev.1999.79.2.387
Reference
  Authors
Fleming I.
  Title
Cytochrome p450 and vascular homeostasis.
  Journal
Circ Res 89:753-62 (2001)
DOI:10.1161/hh2101.099268
Reference
  Authors
Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP
  Title
Molecular mechanism of cGMP-mediated smooth muscle relaxation.
  Journal
Reference
  Authors
Ko EA, Han J, Jung ID, Park WS
  Title
Physiological roles of K+ channels in vascular smooth muscle cells.
  Journal
J Smooth Muscle Res 44:65-81 (2008)
DOI:10.1540/jsmr.44.65
Reference
  Authors
Woodard GE, Rosado JA
  Title
Natriuretic peptides in vascular physiology and pathology.
  Journal
Int Rev Cell Mol Biol 268:59-93 (2008)
DOI:10.1016/S1937-6448(08)00803-4
Reference
  Authors
Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG
  Title
Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide.
  Journal
Am J Physiol Heart Circ Physiol 281:H2337-65 (2001)
DOI:10.1152/ajpheart.2001.281.6.H2337
Reference
  Authors
Hirano K, Hirano M, Kanaide H
  Title
Regulation of myosin phosphorylation and myofilament Ca2+ sensitivity in vascular smooth muscle.
  Journal
J Smooth Muscle Res 40:219-36 (2004)
DOI:10.1540/jsmr.40.219
Reference
PMID:9458738
  Authors
Freeman EJ, Ruehr ML, Dorman RV
  Title
ANG II-induced translocation of cytosolic PLA2 to the nucleus in vascular smooth muscle cells.
  Journal
Am J Physiol 274:C282-8 (1998)
DOI:10.1152/ajpcell.1998.274.1.C282
Reference
  Authors
Murphy TV, Spurrell BE, Hill MA
  Title
Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways.
  Journal
Clin Exp Pharmacol Physiol 29:612-9 (2002)
DOI:10.1046/j.1440-1681.2002.03698.x
Related
pathway
ngi00590  Arachidonic acid metabolism
ngi04020  Calcium signaling pathway
KO pathway
ko04270   
LinkDB

DBGET integrated database retrieval system